We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$525M
AUM Growth
+$86.1M
Cap. Flow
+$50.1M
Cap. Flow %
9.53%
Top 10 Hldgs %
56.68%
Holding
32
New
4
Increased
11
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$29.1M
2
GILD icon
Gilead Sciences
GILD
+$21.8M
3
PFE icon
Pfizer
PFE
+$21.8M
4
MRK icon
Merck
MRK
+$14.8M
5
CNC icon
Centene
CNC
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
26
Rigel Pharmaceuticals
RIGL
$687M
$5.59M 1.06%
159,865
+23,336
+17% +$676K
JNJ icon
27
Johnson & Johnson
JNJ
$657B
$5.51M 1.05%
35,000
-22,116
-39% -$3.26M
ALNY icon
28
Alnylam Pharmaceuticals
ALNY
$38.4B
$3.85M 0.73%
29,615
+10,124
+52% +$1.35M
NVAX icon
29
Novavax
NVAX
$1.18B
$1.28M 0.24%
+11,500
New +$1.22M
A icon
30
Agilent Technologies
A
$39.6B
-169,734
Closed -$17.1M
CLVS
31
DELISTED
Clovis Oncology, Inc.
CLVS
-156,969
Closed -$915K
CERN
32
DELISTED
Cerner Corp
CERN
-26,122
Closed -$1.89M

Similar funds

Sector Gamma AS's Q4 2020 Portfolio in Review

As of Q4 2020, Sector Gamma AS held 32 positions worth $525M, up 20% from $439M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS deployed $50.1M of net new capital in Q4 2020, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Becton Dickinson: 124,891 shares worth $30.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $11.1M trimmed.

  • Sector Gamma AS's largest Q4 2020 buy was Becton Dickinson: 124,891 shares worth $30.5M.
  • Sector Gamma AS added most to Gilead Sciences in Q4 2020, an estimated $21.8M increase.
  • Sector Gamma AS's biggest Q4 2020 reduction was Bristol-Myers Squibb, cutting an estimated $11.1M.
  • Sector Gamma AS fully exited Agilent Technologies in Q4 2020, selling an estimated $17.1M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $525M portfolio in Q4 2020.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q4 2020.
  • Sector Gamma AS's portfolio value rose 20% quarter-over-quarter to $525M.

Based on Sector Gamma AS's 13F filing for Q4 2020, filed 10 Feb 2021.